← Leaderboards
Richard P Polisson
Massachusetts General Hospital
$602,879
Attributed
$602,879
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$602,879 · 1
By mechanism
M01$602,879 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Merit E Cudkowicz$97,012,119
- Steven Kyle Grinspoon$75,757,679
- Jeannie T Lee$25,305,477
- John H Growdon$11,829,523
- Jonathan R Sporn$711,029
Others in their field
Top investigators on “Antirheumatic Agents”
- Cynthia S Crowson · Mayo Clinic Rochester$4,932,117
- Robert M Plenge · Massachusetts Institute Of Technology$4,725,247
- Elizabeth Ann Sugar · Johns Hopkins University$4,502,229
- Janet T. Holbrook · Johns Hopkins University$4,502,229
- Harris R Perlman · Northwestern University$4,365,437
- Daniel Hal Solomon · Brigham And Women'S Hospital$4,136,861
Research focus
Antirheumatic AgentsArthritis TherapyClinical ResearchClinical Trial Phase IDosageDrug Screening /EvaluationHuman SubjectHuman Therapy EvaluationRheumatoid ArthritisSkeletal Disorder Chemotherapy
Grant awards (6)
RO45-2081 FOR PATIENTS WITH RHEUMATOID ARTHRITIS$200,768
M01 · FY2002 · RR
RO45-2081 FOR PATIENTS WITH RHEUMATOID ARTHRITIS$200,768
M01 · FY2002 · RR
RO45-2081 FOR PATIENTS WITH RHEUMATOID ARTHRITIS$200,768
M01 · FY2001 · RR
RO45-2081 FOR PATIENTS WITH RHEUMATOID ARTHRITIS$0
M01 · FY2001 · RR
RO45-2081 FOR PATIENTS WITH RHEUMATOID ARTHRITIS$575
M01 · FY2000 · RR
RO45-2081 FOR PATIENTS WITH RHEUMATOID ARTHRITIS$0
M01 · FY2000 · RR